These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8820264)

  • 1. Catalysed hydrolysis--the complement quickstep.
    Law SK; Dodds AW
    Immunol Today; 1996 Mar; 17(3):105. PubMed ID: 8820264
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activation of thiolester bond containing proteins].
    Ikai A
    Tanpakushitsu Kakusan Koso; 1994 May; 39(7):1184-9. PubMed ID: 7517054
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure and activation of the early components of complement.
    Porter RR
    Fed Proc; 1977 Aug; 36(9):2191-6. PubMed ID: 328305
    [No Abstract]   [Full Text] [Related]  

  • 4. The third (C3) and the fourth (C4) components of complement: labile binding site and covalent bond formation.
    Janatova J
    Ann N Y Acad Sci; 1983; 421():218-34. PubMed ID: 6586100
    [No Abstract]   [Full Text] [Related]  

  • 5. Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2.
    Inal JM; Schifferli JA
    J Immunol; 2002 May; 168(10):5213-21. PubMed ID: 11994478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutants of complement component C3 cleaved by the C4-specific C1-s protease.
    Mathias P; Carrillo CJ; Zepf NE; Cooper NR; Ogata RT
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8125-9. PubMed ID: 1518837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-inhibiting peptides identified by proximity to indels in the C3/4/5 protein family.
    Ogata RT; Low PJ
    J Immunol; 1997 Apr; 158(8):3852-60. PubMed ID: 9103453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramolecular general acid catalysis in the binding reactions of alpha 2-macroglobulin and complement components C3 and C4.
    Davies SG; Sim RB
    Biosci Rep; 1981 Jun; 1(6):461-8. PubMed ID: 6170356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there relationship between SARS-CoV-2 and the complement C3 and C4?
    Dheir H; Sipahi S; Yaylaci S; Köroğlu M; Erdem AF; Karabay O
    Turk J Med Sci; 2020 Jun; 50(4):687-688. PubMed ID: 32421281
    [No Abstract]   [Full Text] [Related]  

  • 10. [Concentration of complement C3 and C4 in sera containing monoclonal IgA or IgG].
    Bartelik S
    Przegl Lek; 1990; 47(2):265-7. PubMed ID: 2356335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum C3 and C4 complement components in ulcerative colitis and Crohn's disease.
    Ward M; Eastwood MA
    Digestion; 1975; 13(1-2):100-3. PubMed ID: 1201816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of the binding specificity of the thioester-containing proteins, C4, C3 and alpha-2-macroglobulin.
    Dodds AW; Law SK
    Complement; 1988; 5(2):89-97. PubMed ID: 2454175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetohydroxamate, a urease inhibitor, inhibits the covalent binding reaction of complement proteins C3 and C4.
    Sim E; Jones A; Stanley L
    Acta Pharmacol Toxicol (Copenh); 1985 Oct; 57(4):304-6. PubMed ID: 4083040
    [No Abstract]   [Full Text] [Related]  

  • 14. The covalent binding reaction of C3 and C4.
    Law SK
    Ann N Y Acad Sci; 1983; 421():246-58. PubMed ID: 6586101
    [No Abstract]   [Full Text] [Related]  

  • 15. Complement activation in glomerulonephritis.
    Baer D
    N Engl J Med; 1977 Jun; 296(22):1299. PubMed ID: 859526
    [No Abstract]   [Full Text] [Related]  

  • 16. [MRNA expression of complement C3 and C4 in rat nasal mucosa with allergic rhinitis].
    Lang JT; Sun AH; Fan JP; Tian SC; Jia R; Cao PY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Dec; 41(12):928-31. PubMed ID: 17345707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perioperative changes of complement (C1q, C3, C4) with cardiopulmonary bypass].
    Wang YT; Xu JX; Zhu YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):86-8, 126-7. PubMed ID: 3264237
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation and fragmentation of the third (C3) and the fourth (C4) components of complement: generation and isolation of physiologically relevant fragments C3c and C4c.
    Janatova J; Gobel RJ
    J Immunol Methods; 1985 Dec; 85(1):17-26. PubMed ID: 4078308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of serum complement (C3 and C4) levels in normal human pregnancy: effect of the development of pregnancy-associated hypertension.
    Gallery ED; Raftos J; Gyory AZ; Wells JV
    Aust N Z J Med; 1981 Jun; 11(3):243-5. PubMed ID: 6945834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Fc Receptor and C4.C3 receptors of the granulocytes from patients with systemic lupus erythematosus.
    Shingu M; Todoroki T; Sakai K; Nobunaga M
    J Rheumatol; 1981; 8(6):910-6. PubMed ID: 7328566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.